Leanbio S.L

Leanbio is a leading Biopharmaceutical CDMO offering end-to-end services in the field of recombinant proteins, mRNA and pDNA.

With over a decade of expertise, we have a proven track record in development and manufacturing of therapeutic molecules such as antibodies, Fab fragments, ADCs, enzymes, complex proteins, mRNA and pDNA. Leanbio has already worked with over 100 candidates over these years, some already in late clinical stages.

Leanbio is expanding its development and manufacturing capabilities with a new GMP site in Barcelona with over 4,000 sqm. and three manufacturing areas: one for mammalian expression systems up to 2000L, another for microbial and yeast up to 1000L, and a third are for mRNA up to 50L. The new facility includes state-of-the-art development laboratories, oustanding Quality control rooms and warehouse.

Leanbio is a global service provider for the development and manufacturing of biologics. Our commitment to excellence is evident in everything we do:

• Prioritizing customer satisfaction.
• Providing cutting-edge end-to-end services.
• Utilizing state-of-the-art facilities.
• Offering extensive expertise in biologics.

Type of Drugs Manufactured:

Biologics

CDMO Services:

Drug Substance Manufacturing (API);Research & Development

No. of Manufacturing Facilities:

1

High Potent Products capabilities:

OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

EMA (Europe)